Business Context and Reporting Period
This Form 8-K is a current report filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on January 18, 2005. The filing discloses the entry into a material definitive agreement regarding executive compensation under the Zimmer Holdings, Inc. 2001 Stock Incentive Plan.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a new stock option grant agreement rather than reporting period financial results.
Material Changes
On January 18, 2005, the Compensation and Management Development Committee approved two types of awards for key employees, including named executive officers J. Raymond Elliott, Sam R. Leno, Bruno A. Melzi, and David C. Dvorak:
- Nonqualified stock options.
- Nonqualified performance-conditioned stock options.
The exercise price for all options is set at the fair market value of the Company's common stock on the grant date. The performance-conditioned options are contingent upon the Company achieving specific performance levels for earnings per share, revenue, and free cash flow for the fiscal year ending December 31, 2005. If achieved, these options vest ratably over a four-year period.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on market outlook, or a discussion of general risks. The primary contingency noted is the vesting of performance-conditioned stock options, which is strictly dependent on meeting the specified financial targets for 2005.
Key Facts for Investor Verification
- Verify the specific performance targets (EPS, revenue, free cash flow) required for the 2005 performance-conditioned stock options, as the exact thresholds are not detailed in this summary text.
- Confirm the total number of shares granted to each named executive officer, as the filing states the number depends on performance achievement.
- Review the attached Exhibit 10.1 for the full legal terms of the performance-conditioned stock option grant award letter.
- Note that the exercise price is fixed at the fair market value on January 18, 2005.